The Grass Valley Development Review Committee (DRC) voted unanimously not to recommend a proposal by AT&T to construct a ...

There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...

A key molecular dynamic could be the key to fighting tumors while allowing patients to still receive life-saving cell ...

OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first quarter of 2026 and recent weeks included ...

At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...

The company’s FLASH2 study was stopped early after failing to show efficacy, shifting focus toward strategic alternatives and ...

Generation Cancer Biotherapeutic Triggers $18 Million Milestone Payment to EvolveImmuneBRANFORD, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, a clinical-stage immuno-oncology ...

Kidney damage is a serious complication affecting individuals with lupus, an autoimmune disease where immune B cells ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing ...

Agreement facilitates flexible, scalable automated industrialized production of rese-cel for many thousands of patients per year at a cost per batch that is among the lowest in the industry ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced it has entered into a ...